Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
181 results about "Matrine" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Matrine is an alkaloid found in plants from the genus Sophora. It has a variety of pharmacological effects, including anti-cancer effects, as well as κ-opioid and μ-opioid receptor agonism. Matrine possesses strong antitumor activities in vitro and in vivo. Inhibition of cell proliferation and induction of apoptosis are the likely mechanisms responsible for matrine's antitumor activities. Matrine is a component of the traditional Chinese medical herb Sophora flavescens Ait.
The invention discloses an indole sophocarpidine derivative photoaffinity active molecular probe which is formed by connecting an active group and a reactive group, the active group is a sophocarpidine derivative, the reactive group is a substance containing a diaziridine group and an alkyne group, and the chemical formula of the sophocarpidine derivative is as shown in the formula I. The invention further discloses a preparation method of the indole sophocarpidine derivative photoaffinity active molecular probe. After Spodoptera frugiperda Sf9 cells are treated by the indole sophocarpidine derivative photoaffinity active molecular probe for 72 hours, the inhibition rate can reach 86.33%, potential target protein when the sophocarpidine derivative acts on the Sf9 cells can be determined by utilizing the indole sophocarpidine derivative photoaffinity active molecular probe, targeted modification of sophocarpidine is facilitated, and the application range of the indole sophocarpidine derivative photoaffinity active molecular probe is widened. Further, matrine pesticides with excellent insecticidal activity are efficiently synthesized, and agricultural pests are better prevented and controlled.
The invention discloses an anti-tumor matrine hydrazine thiazole derivative and a preparation method and application thereof.The preparation method comprises the steps that NaH is added into a first reaction container, then a DMF solution is added, thiosemicarbazide is added into the first reaction container, and the solution is stirred; adding sophocarpidine into the stirred solution to perform reflux reaction, performing quenching reaction after the reaction is finished, and performing extraction, concentration drying and column chromatography separation to obtain a thiosemicarbazide sophocarpidine intermediate; adding the obtained thiosemicarbazide matrine intermediate into a reaction container II, and adding a dissolving solventethanol for dissolving; adding alpha-bromo-R-ethyl ketone into the dissolved solution for reaction, concentrating and drying after the reaction is finished, and performing column chromatography separation to obtain the anti-tumor matrine hydrazine thiazole derivative. The anti-tumor matrine hydrazine thiazole derivative is high in anti-tumor activity, the preparation method is simple and convenient, and reaction conditions are easy to control.
The invention discloses matrine-oleanolic acidionic liquid and a preparation method and application thereof.The preparation method comprises the steps that matrine and oleanolic acid are dissolved in an organic solvent, heating and stirring are conducted, then rotary evaporation is conducted, and the matrine-oleanolic acidionic liquid is obtained; wherein the mass ratio of the sum of the matrine and the oleanolic acid to the organic solvent is 1: (5-30), and the molar ratio of the matrine to the oleanolic acid is (3-10): 1. The ionic liquid disclosed by the invention not only can effectively improve the water solubility of oleanolic acid, but also can effectively inhibit the activity of 5 alpha-reductase and prevent the 5 alpha-reductase from catalyzing testosterone to be converted into DHT, so that the problems of rapid entry into a retrogression period, miniaturization, hair loss and the like caused by the fact that DHT acts on hair follicles after being combined with an androgenreceptor are prevented. Meanwhile, expression of IL-1beta and TNF-alpha inflammatory factors in skin hair follicles can be inhibited, and the purposes of preventing alopecia and promoting hair growth are achieved. The effects of controlling oil, resisting inflammation, relieving, removing dandruff, relieving itching and the like are also achieved.
The invention provides a matrine-natural polyphenol amorphous substance as well as a preparation method and application thereof, and relates to the technical field of polyphenol and alkaloidpharmacy, in the matrine-natural polyphenol amorphous substance, the molar ratio of matrine to natural polyphenol is (1-2): (1-2), through strong interaction between matrine and polyphenol substances, the matrine-natural polyphenol amorphous substance can be used for preparing the natural polyphenol, and the matrine-natural polyphenol amorphous substance can be used for preparing the natural polyphenol. The physicochemical properties of the medicine in the amorphous substance, such as solubility, polarity and lipid-water partition coefficient, are changed, the slow release of the medicine is realized, and the IC50 value of the amorphous substance is reduced; in addition, matrine and polyphenol substances exert synergistic anti-oxidative stress capability, the ROS (reactive oxygen species) level of cells is reduced, and the toxicity of natural polyphenols to the cells is further reduced.
The invention relates to a temperature-sensitive gel nose drop and a preparation method and application thereof, and belongs to the technical field of biological medicines.The temperature-sensitive gel nose drop is composed of a temperature-sensitive gel matrix, active ingredients and pharmaceutic adjuvants, the temperature-sensitive gel matrix comprises poloxamer 407 and poloxamer 188, the active ingredients comprise matrine and oxymatrine, and the pharmaceutic adjuvants comprise the temperature-sensitive gel matrix, the active ingredients and the pharmaceutic adjuvants. The pharmaceutic adjuvants comprise one or more of a solvent, a humectant, an antioxidant, a preservative, a wetting agent, a thickening agent, a coloring agent, a wetting agent and a buffering agent. The temperature-sensitive gel nose drop disclosed by the invention is simple in preparation process, controllable in cost and suitable for large-scale production. The thermo-sensitive gel nose drop can improve the expression level of serum IgE, IL-4 and IFN-gamma, improves the symptom of allergic rhinitis by correcting Th1 / Th2 imbalance, is suitable for clinical treatment and prevention of allergic rhinitis, and has a remarkable clinical application prospect.
The invention belongs to the field of crop genetic breeding, and relates to cultivation of plants with high matrine and oxymatrine content. In particular discloses a transcription factor for positively regulating matrine and oxymatrine in plants, and a nucleotide sequence of the transcription factor has 90% similarity with a sequence as shown in SEQ ID No.1. Furthermore, the nucleotide sequence of the transcription factor is as shown in SEQ ID No. 1. By constructing an overexpression vector of a subprostrate sophora transcription factor (StNAC46 gene) and performing genetic transformation on the overexpression vector, it is proved that the StNAC46 gene can improve accumulation of matrine and oxymatrine in plants, and a new thought is provided for cultivation and production of subprostrate sophora with high matrine and oxymatrine content.
The invention relates to the field of biological pharmacy, in particular to application of matrine in preparation of an intestinal microbiota regulator and an anti-escherichia coli medicine. The invention provides application of matrine in preparation of an intestinal microbiota regulator and an anti-Escherichia coli medicine, and matrine has the following advantages in application: (1) an active compound of a plant source has the characteristics of specificity and naturalness, and is friendly to the ecological environment; (2) the chemical structure and chemical characteristics are known, and the compound plays a role together with the immune system and the like of a host; (3) the main mode of acting on pathogens is a weakening and inhibiting mechanism or a synergistic effect with other substances, so that the drug resistance of pathogenic microorganisms is not easily caused, and the effectiveness of long-term use is ensured; and (4) pathogenic bacteria cannot be directly and completely killed generally, and corresponding pathogenic microorganisms are inhibited in a way of controlling an ecological steady state, so that the survival, replication and proliferation of the microbial community cannot be seriously influenced.
The present application relates to the application of traditional Chinese medicineactive ingredient composition and its preparation in synergistic anti-tumor of PD-1 inhibitor. The traditional Chinese medicineactive ingredient composition is a composition of oxymatrine and astragaloside B. The combination of the two can improve the anti-tumor effect of PD-1 inhibitor. In addition, it can also be used in the form of preparation to realize in vivodrug delivery in cooperation with its pharmaceutically acceptable carrier. The carrier can be selected from iron-based MOF and liposome, etc. to realize the co-loading of oxymatrine and astragaloside B with different polarity and efficient drug delivery. The iron-based MOF carrier has the advantages of high drug loading capacity and Fe ion which can cooperate with astragaloside B to improve the activity of tumor infiltrating T cells. The ferromagnetism and platelet membrane modification can also precisely target tumor tissue. The preparation technology of liposome is mature, which is conducive to industrialized production and has broad prospects for clinical transformation. The combination of the two with PD-1 inhibitor can significantly improve the anti-tumor effect of PD-1 inhibitor.
The invention discloses a matrine slow-release agent as well as a preparation method and application thereof, and belongs to the technical field of pesticides. The preparation method comprises the following steps: firstly, dissolving matrine in an acidic aqueous solution, then sequentially adding carboxyl cellulose and fatty amine into the solution, stirring and emulsifying to obtain a dispersion liquid, and finally, adding the dispersion liquid into vegetable oil, and carrying out secondary emulsification to obtain the W / O / W Pickering emulsion. The sophocarpidine is combined and self-assembled through non-covalent bonds to form the drug-loaded gel, a wrapping structure is formed, the stability of the drug-loaded gel is effectively improved, and meanwhile the slow release performance of drug molecules is achieved through the non-covalent bond combination form; and vegetable oil is used for encapsulation, so that the stability of matrine molecules is further ensured, the matrine has better affinity with the plant surface, and the wettability is improved.
The application discloses a phloretin-matrine co-crystal and a preparation method and application thereof, relates to the technical fields of natural active ingredientcrystal modification, daily chemical raw materials and skin external drugs, and has the characteristic diffraction peaks of X-raypowderdiffraction patterns at diffraction angles 2theta of 7.2°, 10.4°, 14.8°, 18.2°, 22.6° and 26.0°, and the relative peak intensities of the peaks are 100%, 89%, 81%, 76%, 65% and 58% respectively, wherein the error tolerance of the diffraction angle is ±0.2°; the molar ratio of phloretin to matrine in the co-crystal is 1:1; and the co-crystal is a yellow crystalline solid; the liquid-assisted grinding method and the anti-solventcrystallization method are used to construct the co-crystal with a fixed molar ratio of phloretin to matrine, the solubility and stability are improved, the co-crystal is uniformly dispersed, the co-crystal has the effects of anti-inflammation, soothing and antioxidation, the two mild processes can be flexibly prepared, and the co-crystal is suitable for the fields of daily chemicals and medicines.
The invention belongs to the technical field of cell culture, discloses a multiplication culture method of peripheral blood gamma delta T cells, and particularly discloses application of matrine in multiplication culture of gamma delta T cells. Matrine is alkaloid which is extracted from traditional Chinese medicines and has various pharmacological activities, and has wide anti-tumor and anti-inflammatory activities. Matrine with a proper concentration is added into the gamma delta T cell culture medium, so that the amplification quantity of gamma delta T cells can be effectively increased, and the cell culture cost is reduced; meanwhile, the matrine component in the culture medium can effectively improve the killing activity of the gamma delta T cells on tumor cells, and the clinical immunotherapy effect is further improved.
The invention relates to the technical field of drug carriers, in particular to a mesoporous nanomaterial coupled with a CCR2 antibody and a preparation method and application of the mesoporous nanomaterial. According to the invention, the aminated mesoporous material is used for loading the drug and is coupled with the CCR2 antibody, so that the obtained CCR2 antibody coupled mesoporous nano material can target CCR2 + macrophages, the bioavailability of drugs such as matrine is improved, and the side effect is reduced. According to the invention, leading-edge technical elements such as a mesoporous nano-carrier, CCR2 antibody targeted modification and macrophage precise delivery are introduced, so that a carrier-drug-antibody ternary innovative combination system is formed.
The invention relates to the technical field of medicinal chemistry, and particularly discloses application of echinacoside in preparation of a medicine for improving autism social and cognitive impairment, and the application comprises the following steps: constructing a recombinant saccharomyces cerevisiae strain, and knocking out a precursor competition pathway gene; performing metabolic flow reprogrammingfermentation on the recombinant strain; centrifuging the fermentation liquor at 7000-9000 r / min and pretreating the fermentation liquor with an 8-12 kDa ultrafiltration membrane; carrying out dual-targeting affinity chromatography purification on the pretreatment liquid; the preparation method comprises the following steps: preparing echinacoside into a liposome containing pH sensitive poly-histidine; and adding a freeze-drying protective agent into the suspension to carry out gradient pre-freezing and vacuum freeze-drying. According to the application, a mode of combining recombinant saccharomyces cerevisiae strain construction and metabolic flow reprogramming fermentation is adopted, targeted enrichment of echinacoside is realized through affinity chromatography coupled with autismbrain region specific double ligands, then the echinacoside is prepared into the liposome containing pH sensitive poly-histidine, the double ligands are modified, and the effects of precise targeting and efficient effect are achieved.
The invention belongs to the technical field of medicinal chemistry, and particularly relates to application of matrine combined with medroxyprogesterone acetate in preparation of antitumor drugs. According to the invention, matrine and medroxyprogesterone are combined for use, and the matrine and medroxyprogesterone are used for developing products such as drugs, preparations, kits and the like for treating endometrial cancer. Experimental results prove that after sophocarpidine and medroxyprogesterone acetate are combined for medication, the composition shows relatively strong activity of inhibiting endometrial cancer and relatively good synergistic inhibition effect, so that the composition has relatively good practical application value. Experimental results prove that the dosages of the two can be remarkably reduced after drug combination, and the anti-tumor effect is remarkably improved. Animal experiments show that in-vivo anti-tumor effects of sophocarpidine and medroxyprogesterone acetate can be improved by combined medication compared with that of single medication. In conclusion, the combined medication of the matrine and the medroxyprogesterone can become a new method for treating endometrial cancer patients.
The application discloses an anti-tumor matrine hydrazine thiazole derivative and a preparation method and application thereof, NaH is added into a reaction container one, then a DMF solution is added, and then aminothiourea is added into the reaction container one to stir the solution; sophoridine is added into the stirred solution to perform a reflux reaction, after the reaction is completed, a quenching reaction is performed, and then extraction, concentration drying and column chromatography separation are performed to obtain an aminothiourea matrine intermediate; the obtained aminothiourea matrine intermediate is added into a reaction container two, and an ethanol dissolving solvent is added to dissolve; the dissolved solution is added with alpha-bromo R base ethanone to perform a reaction, after the reaction is completed, concentration drying and column chromatography separation are performed to obtain the anti-tumor matrine hydrazine thiazole derivative. The anti-tumor matrine hydrazine thiazole derivative has strong anti-tumor activity, and the preparation method is simple and the reaction condition is easy to control.